rs546307383
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_138691.3(TMC1):c.2260+3_2260+5delTGG variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000501 in 1,612,858 control chromosomes in the GnomAD database, including 4 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_138691.3 splice_region, intron
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive nonsyndromic hearing loss 7Inheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
- nonsyndromic genetic hearing lossInheritance: SD, AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen
- autosomal dominant nonsyndromic hearing loss 36Inheritance: AD, AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia
- autosomal dominant nonsyndromic hearing lossInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -16 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TMC1 | NM_138691.3 | c.2260+3_2260+5delTGG | splice_region_variant, intron_variant | Intron 23 of 23 | ENST00000297784.10 | NP_619636.2 | ||
| TMC1 | XM_017014256.2 | c.2263+3_2263+5delTGG | splice_region_variant, intron_variant | Intron 20 of 20 | XP_016869745.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TMC1 | ENST00000297784.10 | c.2260+3_2260+5delTGG | splice_region_variant, intron_variant | Intron 23 of 23 | 1 | NM_138691.3 | ENSP00000297784.6 |
Frequencies
GnomAD3 genomes AF: 0.00275 AC: 418AN: 152020Hom.: 2 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000645 AC: 162AN: 251026 AF XY: 0.000442 show subpopulations
GnomAD4 exome AF: 0.000266 AC: 389AN: 1460726Hom.: 2 AF XY: 0.000213 AC XY: 155AN XY: 726668 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00275 AC: 419AN: 152132Hom.: 2 Cov.: 32 AF XY: 0.00246 AC XY: 183AN XY: 74376 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:2
- -
- -
not specified Benign:1
c.2260+3_2260+5delTGG in intron 23 of TMC1: This variant is not expected to have clinical significance because it has been identified in 0.8% (86/10328) of Afri can chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinst itute.org; dbSNP rs546307383). In addition, computational tools do not predict a n impact to splicing. -
TMC1-related disorder Benign:1
This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at